ClinicalTrials.Veeva

Menu

Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV

H

Huazhong University of Science and Technology

Status

Unknown

Conditions

Uterine Cervical Cancer
Uterine Cervical Neoplasm
Cervical Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Most uterine cervical high-risk human papillomavirus (HPV) infections are transient, with only a small fraction developing into cervical cancer. Family aggregation studies and heritability estimates suggest a significant inherited genetic component. Candidate gene studies and previous genome-wide association studies (GWASs) report associations between the HLA region and cervical cancer. Adopting a genome-wide approach, we aimed to establish an early warning model for a high-risk population of cervical cancer.

Enrollment

20,000 estimated patients

Sex

Female

Ages

25 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • (1) Case group a) Aged 25-75 years. b) Han nationality. c) Patients with cervical cancer or cervical precancerous lesions above CIN2 diagnosed by biopsy or postoperative pathological diagnosis.
  • (2) Control group: a) Aged 25-75 years. b) Han nationality. c) No family history of cervical cancer or precancerous lesions. d) The results of TCT examination showed no abnormality.

Exclusion criteria

  • (1) suffering from other neoplastic diseases.
  • (2) pregnant women.
  • (3) those with a history of bone marrow transplantation.

Trial contacts and locations

1

Loading...

Central trial contact

Ding Ma, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems